tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IVBXF Stock Latest News

Innovent Biologics announces multiple mechanism-of-action analyses of mazdutide
The FlyInnovent Biologics announces multiple mechanism-of-action analyses of mazdutide
2d ago
Innovent Biologics announces first participant dosed in Phase 3 GLORY-OSA
PremiumThe Fly
Innovent Biologics announces first participant dosed in Phase 3 GLORY-OSA
8d ago
Innovent Biologics’ New Drug Application for Advanced Renal Cell Carcinoma Accepted in China
PremiumCompany Announcements
Innovent Biologics’ New Drug Application for Advanced Renal Cell Carcinoma Accepted in China
19d ago
Innovent Biologics Announces Annual General Meeting and Key Resolutions
PremiumCompany Announcements
Innovent Biologics Announces Annual General Meeting and Key Resolutions
22d ago
Innovent Biologics Reports Over 40% Revenue Growth in Q1 2025
PremiumCompany Announcements
Innovent Biologics Reports Over 40% Revenue Growth in Q1 2025
2M ago
Innovent Biologics’ Limertinib Gains Approval for First-Line Lung Cancer Treatment
PremiumCompany AnnouncementsInnovent Biologics’ Limertinib Gains Approval for First-Line Lung Cancer Treatment
2M ago
Innovent Biologics Announces Board Changes
Premium
Company Announcements
Innovent Biologics Announces Board Changes
3M ago
Innovent Biologics Announces Board of Directors Composition
Premium
Company Announcements
Innovent Biologics Announces Board of Directors Composition
3M ago
Innovent Biologics Updates Nomination Committee Terms
PremiumCompany Announcements
Innovent Biologics Updates Nomination Committee Terms
3M ago
Innovent Biologics: Strong Financial Performance and Promising Growth in Oncology and Beyond
PremiumRatings
Innovent Biologics: Strong Financial Performance and Promising Growth in Oncology and Beyond
3M ago
Innovent Biologics Grants Share Options to Key Personnel
PremiumCompany Announcements
Innovent Biologics Grants Share Options to Key Personnel
3M ago
Innovent Biologics Reports Strong 2024 Financial Results
PremiumCompany Announcements
Innovent Biologics Reports Strong 2024 Financial Results
3M ago
Innovent Biologics Achieves Historic Financial Milestone in 2024
PremiumCompany AnnouncementsInnovent Biologics Achieves Historic Financial Milestone in 2024
3M ago
Innovent Biologics’ SYCUME® Gains Approval as China’s First IGF-1R Antibody for Thyroid Eye Disease
Premium
Company Announcements
Innovent Biologics’ SYCUME® Gains Approval as China’s First IGF-1R Antibody for Thyroid Eye Disease
3M ago
Innovent Biologics Schedules Board Meeting to Approve Annual Results
Premium
Company Announcements
Innovent Biologics Schedules Board Meeting to Approve Annual Results
3M ago
Innovent Biologics Achieves Milestone with Priority Review for Cancer Treatment
PremiumCompany Announcements
Innovent Biologics Achieves Milestone with Priority Review for Cancer Treatment
4M ago
Innovent Biologics Achieves Strong Revenue Growth and Plans Major Expansions in 2025
PremiumCompany Announcements
Innovent Biologics Achieves Strong Revenue Growth and Plans Major Expansions in 2025
5M ago
Innovent Biologics’ Limertinib Gains Approval for Advanced Lung Cancer Treatment
PremiumCompany Announcements
Innovent Biologics’ Limertinib Gains Approval for Advanced Lung Cancer Treatment
5M ago
Innovent Biologics Reports Unusual Market Activity Amid Growth Plans
PremiumCompany Announcements
Innovent Biologics Reports Unusual Market Activity Amid Growth Plans
5M ago
Innovent Biologics Gains Approval for New Cancer Drug
PremiumCompany AnnouncementsInnovent Biologics Gains Approval for New Cancer Drug
6M ago
Innovent Biologics Partners with Roche for ADC Development
Premium
Company Announcements
Innovent Biologics Partners with Roche for ADC Development
6M ago
Innovent Biologics Unveils Board Composition and Leadership
Premium
Company Announcements
Innovent Biologics Unveils Board Composition and Leadership
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >